Could 3 shots instead of 4 control wet AMD? new study says maybe

This study looked at 742 older adults with wet age-related macular degeneration (nAMD) who had never been treated before. They received three monthly injections of faricimab, a drug that targets two proteins to reduce abnormal blood vessel growth and leakage. The goal was to see how long the effect lasted before another injection was needed. Results help doctors understand if a shorter loading phase can still control the disease and reduce the number of future eye injections.